Moderna Adjusts Vaccine Trial Protocol, Delays Start of Testing
Moderna, one of the front-runners in the race to develop an effective SARS-CoV-2 vaccine, is adjusting its clinical trial protocol, which will delay the start of a 30,000 subject human trial on the vaccine, which was scheduled to start July…